Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - Nasdaq - IL0010952641 - Common Stock - Currency: USD

89.4  -0.06 (-0.07%)

After market: 89.4 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CAMT. CAMT was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While CAMT has a great profitability rating, there are some minor concerns on its financial health. CAMT is valued quite expensive, but it does show an excellent growth. This makes CAMT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
Each year in the past 5 years CAMT has been profitable.
In the past 5 years CAMT always reported a positive cash flow from operatings.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of CAMT (13.67%) is better than 84.55% of its industry peers.
The Return On Equity of CAMT (21.72%) is better than 88.18% of its industry peers.
CAMT has a better Return On Invested Capital (13.44%) than 84.55% of its industry peers.
CAMT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is in line with the industry average of 10.58%.
The last Return On Invested Capital (13.44%) for CAMT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.67%
ROE 21.72%
ROIC 13.44%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 28.32%, CAMT belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
CAMT's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 26.72%, CAMT belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
In the last couple of years the Operating Margin of CAMT has grown nicely.
CAMT has a better Gross Margin (50.34%) than 60.91% of its industry peers.
In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 26.72%
PM (TTM) 28.32%
GM 50.34%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

CAMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CAMT has been increased compared to 1 year ago.
CAMT has more shares outstanding than it did 5 years ago.
CAMT has a better debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 9.23 indicates that CAMT is not in any danger for bankruptcy at the moment.
CAMT's Altman-Z score of 9.23 is fine compared to the rest of the industry. CAMT outperforms 74.55% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that CAMT is not too dependend on debt financing.
CAMT's Debt to Equity ratio of 0.34 is on the low side compared to the rest of the industry. CAMT is outperformed by 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 9.23
ROIC/WACC1.09
WACC12.36%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

CAMT has a Current Ratio of 5.27. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.27, CAMT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CAMT has a Quick Ratio of 4.26. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.26, CAMT is doing good in the industry, outperforming 76.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.27
Quick Ratio 4.26
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
The Earnings Per Share has been growing by 34.86% on average over the past years. This is a very strong growth
Looking at the last year, CAMT shows a very strong growth in Revenue. The Revenue has grown by 32.65%.
The Revenue has been growing by 26.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)37.5%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%25.4%
Revenue 1Y (TTM)32.65%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%22.29%

3.2 Future

CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.04% yearly.
CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.16% yearly.
EPS Next Y16.18%
EPS Next 2Y12.7%
EPS Next 3Y11.93%
EPS Next 5Y17.04%
Revenue Next Year14.48%
Revenue Next 2Y11.56%
Revenue Next 3Y11.08%
Revenue Next 5Y16.16%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

CAMT is valuated quite expensively with a Price/Earnings ratio of 30.10.
CAMT's Price/Earnings ratio is a bit cheaper when compared to the industry. CAMT is cheaper than 66.36% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CAMT is valued at the same level.
The Price/Forward Earnings ratio is 25.05, which means the current valuation is very expensive for CAMT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 61.82% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CAMT is around the same levels.
Industry RankSector Rank
PE 30.1
Fwd PE 25.05
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CAMT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.51
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CAMT may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)0.86
EPS Next 2Y12.7%
EPS Next 3Y11.93%

0

5. Dividend

5.1 Amount

CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAMTEK LTD

NASDAQ:CAMT (7/11/2025, 8:00:02 PM)

After market: 89.4 0 (0%)

89.4

-0.06 (-0.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners53.69%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap4.08B
Analysts84
Price Target86.81 (-2.9%)
Short Float %10.97%
Short Ratio7.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.81%
Min EPS beat(2)0.51%
Max EPS beat(2)1.1%
EPS beat(4)4
Avg EPS beat(4)2.1%
Min EPS beat(4)0.51%
Max EPS beat(4)6.06%
EPS beat(8)8
Avg EPS beat(8)3.66%
EPS beat(12)11
Avg EPS beat(12)2.6%
EPS beat(16)13
Avg EPS beat(16)2.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.42%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.23%
Revenue beat(12)2
Avg Revenue beat(12)-0.78%
Revenue beat(16)4
Avg Revenue beat(16)-0.5%
PT rev (1m)0%
PT rev (3m)-22.63%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)1.15%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)-0.4%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 30.1
Fwd PE 25.05
P/S 9.04
P/FCF N/A
P/OCF N/A
P/B 6.93
P/tB 8.12
EV/EBITDA 32.51
EPS(TTM)2.97
EY3.32%
EPS(NY)3.57
Fwd EY3.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.89
BVpS12.89
TBVpS11.01
PEG (NY)1.86
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 13.67%
ROE 21.72%
ROCE 14.95%
ROIC 13.44%
ROICexc 13.44%
ROICexgc 15.04%
OM 26.72%
PM (TTM) 28.32%
GM 50.34%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexcg growth 3Y-39.43%
ROICexcg growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 1.51
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.27
Quick Ratio 4.26
Altman-Z 9.23
F-ScoreN/A
WACC12.36%
ROIC/WACC1.09
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%25.4%
EPS Next Y16.18%
EPS Next 2Y12.7%
EPS Next 3Y11.93%
EPS Next 5Y17.04%
Revenue 1Y (TTM)32.65%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%22.29%
Revenue Next Year14.48%
Revenue Next 2Y11.56%
Revenue Next 3Y11.08%
Revenue Next 5Y16.16%
EBIT growth 1Y62.24%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year23.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%